We have recently initiated another trial aimed at investigating the long-term effects of low-to-medium dosage supplementation with guanidinoacetic acid (GAA). Among other objectives, we are eager to gain a deeper understanding of the methylation requirements associated with GAA intake, as well as its utilization within the context of a regular diet in the healthy population. This research will offer additional evidence to inform decisions regarding the appropriate dosage of GAA for human nutrition.